Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer

2004 • 10,779 citations

The biology of VEGF and its receptors

2003 • 9,272 citations

Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis

1996 • 6,878 citations

RAG-1-deficient mice have no mature B and T lymphocytes

1992 • 2,859 citations

A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer

2003 • 2,723 citations

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

2000 • 2,700 citations

Regulation of angiogenesis by hypoxia: role of the HIF system

2003 • 2,404 citations

Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF

1999 • 2,176 citations

Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes

1985 • 1,292 citations

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

2003 • 1,276 citations

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

2003 • 1,236 citations

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

2003 • 1,172 citations

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

2000 • 1,159 citations

Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice

1998 • 1,077 citations

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1

2002 • 1,066 citations

Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice

1999 • 990 citations

A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor.

1992 • 807 citations

De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent

2005 • 785 citations

Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1+ stem cells from bone-marrow microenvironment

2002 • 638 citations

Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis

2004 • 618 citations

Vascular reactions to histamine, histamine‐liberator and leukotaxine in the skin of guinea‐pigs

1952 • 535 citations

Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene.

1988 • 523 citations

Structure and Function of VEGF/VEGF-receptor System Involved in Angiogenesis.

2001 • 508 citations

Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans

2001 • 504 citations

Effect of p53 Status on Tumor Response to Antiangiogenic Therapy

2002 • 427 citations

VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic β cell carcinogenesis

2002 • 372 citations

Antiangiogenic therapy of transgenic mice impairs de novo tumor growth.

1996 • 349 citations

Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis.

1997 • 330 citations

Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo

2002 • 317 citations

VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis

2005 • 281 citations

Non-tolerance and autoantibodies to a transgenic self antigen expressed in pancreatic β cells

1987 • 269 citations

Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches.

2001 • 238 citations

Fibroblast growth factors are required for efficient tumor angiogenesis.

2000 • 229 citations

Antiangiogenic Therapy of Cerebral Melanoma Metastases Results in Sustained Tumor Progression via Vessel Co-Option

2004 • 226 citations

T-cell tolerance toward a transgenic beta-cell antigen and transcription of endogenous pancreatic genes in thymus.

1994 • 223 citations

Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis.

1995 • 195 citations

Immune Enhancement of Skin Carcinogenesis by CD4+ T Cells

2003 • 182 citations

A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer

2005 • 159 citations

Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revascularization

2003 • 136 citations

Biological Activity and Phosphorylation Sites of the Bacterially Expressed Cytosolic Domain of the KDR VEGF-Receptor

1994 • 112 citations

Inhibition of VEGF-Dependent Multistage Carcinogenesis by Soluble EphA Receptors

2003 • 97 citations

Resistance to cytotoxic and anti-angiogenic anticancer agents: similarities and differences

2003 • 89 citations

Transformation of the microvascular system during multistage tumorigenesis

2002 • 88 citations

Angiogenesis inhibitors: motivators of metastasis?

2003 • 79 citations

CD4+ T Cell-Mediated Antigen-Specific Immunotherapy in a Mouse Model of Cervical Cancer

2005 • 77 citations

Can tumor angiogenesis be inhibited without resistance?

2005 • 69 citations

The Snark is a Boojum: the continuing problem of drug resistance in the antiangiogenic era

2002 • 38 citations